Physicochemical properties and immunological effects of macrophage membrane-coated PLGA nanoparticles loaded with Hericium erinaceus polysaccharides
Source abstract
Abstract
In this study, we developed biomimetic Hericium erinaceus polysaccharides PLGA nanoparticles (NPs) coated with macrophage membrane (MM-PLGA-HEP) and examined their immune activity in vitro and in vivo. Nanoparticle characterization revealed that from HEP to MM-PLGA-HEP, there was an increase in negative surface charge (with enhanced stability), structural changes, and a morphological transition from porous HEP sheets to spherical MM-PLGA-HEP. In vitro evaluations confirmed that MM-PLGA-HEP exhibited no cytotoxicity, significantly enhanced macrophage proliferation, dose-dependently stimulated nitric oxide secretion, and uptake studies confirmed its superior internalization efficiency in macrophages. In vivo administration of MM-PLGA-HEP in mice revealed significant improvements in spleen and liver indices, splenic lymphocyte proliferation, macrophage phagocytosis, and CD40/CD86 expression, indicating robust immune activation. Furthermore, MM-PLGA-HEP induced sustained antigen release, resulting in elevated IgG levels and enhanced humoral immune responses compared to controls. These findings underscore the potential of MM-PLGA-HEP as a novel nanocarrier for targeted drug delivery and vaccine adjuvant applications, providing a promising platform for enhanced immunotherapy and antigen-specific delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Polysaccharides and Plant Cell Walls · Pharmacological Effects of Natural Compounds · Silymarin and Mushroom Poisoning
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Enhanced Staphylococcus aureus protection by uncoupling of the α-toxin-ADAM10 interaction during murine neonatal vaccination10.1038/s41467-024-52714-7 ↗
2. Vaccine adjuvants: mechanisms and platforms10.1038/s41392-023-01557-7 ↗
3. Cytosolic dsRNA improves neonatal innate immune responses to adjuvants in use in pediatric vaccines10.1002/JLB.5A0521-242R ↗
4. AS03- and MF59-adjuvanted influenza vaccines in children10.3389/fimmu.2017.01760 ↗
5. Development of a water-in-oil-in-water adjuvant for foot-and-mouth disease vaccine based on ginseng stem-leaf saponins as an immune booster10.1016/j.cimid.2020.101499 ↗
6. Cancer vaccine therapeutics: limitations and effectiveness-a literature review10.3390/cells12172159 ↗
7. Extraction of polysaccharides from Codonopsis pilosula by fermentation with response surface methodology10.1002/fsn3.1958 ↗
8. How do adjuvants enhance immune responses?10.7554/eLife.101259 ↗
9. Immunomodulatory effects of hydroxyethylated Hericium erinaceus polysaccharide on macrophages RAW264.710.1016/j.ijbiomac.2017.07.104 ↗
10. Molecular properties, structure, and antioxidant activities of the oligosaccharide Hep-2 isolated from cultured mycelium of Hericium erinaceus10.1111/jfbc.12985 ↗
11. Resveratrol-loaded sulfated Hericium erinaceus β-glucan-chitosan nanoparticles: preparation, characterization and synergistic anti-inflammatory effects10.1016/j.carbpol.2024.121916 ↗
12. Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases10.1016/j.biopha.2021.111377 ↗
13. Macrophage membrane-biomimetic multi-layered nanoparticles targeting synovial angiogenesis for osteoarthritis therapy
14. Ordered conformation-regulated vesicular membrane permeability10.1002/anie.202109637 ↗
15. Cell membrane-mimicking coating for blood-contacting polyurethanes10.1177/0885328214549611 ↗
16. Bioinspired porous membranes containing polymer nanoparticles for wound healing
17. Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles10.1038/s41565-024-01618-0 ↗
18. Dendritic mesoporous nanoparticles: structure, synthesis and properties10.1002/anie.202112752 ↗
19. Tailoring the inherent properties of biobased nanoparticles for nanomedicine10.1021/acsbiomaterials.3c00364 ↗
20. Nanoinformatics based insights into the interaction of blood plasma proteins with carbon based nanomaterials: implications for biomedical applications10.1016/bs.apcsb.2023.11.015 ↗
21. Nanoparticle-based dressing: the future of wound treatment?10.1016/j.tibtech.2017.05.005 ↗
22. Poly(lactic-co-glycolic) acid (PLGA) nanoparticles and transdermal drug delivery: an overview10.2174/0113816128275385231027054743 ↗
23. Poly (lactic-co-glycolic acid) nanoparticle-based vaccines delivery systems as a novel adjuvant for H9N2 antigen enhance immune responses10.1016/j.psj.2022.101791 ↗
24. Nitro-oleic acid, a ligand of CD36, reduces cholesterol accumulation by modulating oxidized-LDL uptake and cholesterol efflux in RAW264.7 macrophages10.1016/j.redox.2020.101591 ↗
25. Preparation, characterization and immune response of chitosan gold loaded Myricaria germanica polysaccharide
26. Preparation and adjuvanticity against PCV2 of Viola philippica polysaccharide loaded in chitosan-gold nanoparticle10.1016/j.vaccine.2024.03.009 ↗
27. Determination of protein molecular weights on SDS-PAGE10.1007/978-1-4939-8793-1_10 ↗
28. Concanavalin A-induced autoimmune hepatitis model in mice: mechanisms and future outlook
29. Effect of Pinus pinaster and Pinus radiata resin on biomass growth of Fusarium circinatum
30. Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro10.1186/s12951-019-0490-2 ↗
31. Poly((D,L)lactic-glycolic) acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting10.2147/IJN.S147668 ↗
32. Characterization of commercial PLGAs by NMR spectroscopy10.1007/s13346-021-01061-x ↗
33. Mannose-modified PLGA nanoparticles for sustained and targeted delivery in Hepatitis B virus immunoprophylaxis10.1208/s12249-019-1526-5 ↗
34. Macrophage reprogramming and cancer therapeutics: role of iNOS-derived NO10.3390/cells10113194 ↗
35. Co-delivery of dual toll-like receptor agonists and antigen in Poly(Lactic-Co-Glycolic) acid/ Polyethylenimine cationic hybrid nanoparticles promote efficient in vivo immune responses10.3389/fimmu.2017.01077 ↗
36. Regulation of adaptive immune responses by guiding cell movements in the spleen10.3389/fmicb.2015.00645 ↗
37. The influence of Salvia cadmica Boiss. extracts on the M1/M2 polarization of macrophages primed with Helicobacter pylori lipopolysaccharide in conjunction with NF-kappa B activation, production of cytokines, phagocytic activity and total DNA methylation
38. Ras isoforms: signaling specificities in CD40 pathway10.1186/s12964-019-0497-1 ↗
39. CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells10.1371/journal.pone.0045185 ↗
40. Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection10.3201/eid2902.221422 ↗
41. Distinctive localization of antigen-presenting cells in human lymph nodes10.1182/blood-2008-06-165266 ↗
42. Remembrance of things past: long-term B cell memory after infection and vaccination10.3389/fimmu.2019.01787 ↗
43. Althwaiqeb · 2024
44. Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles10.1007/s11095-011-0459-9 ↗
45. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy10.1186/s12951-022-01453-2 ↗
46. Re-inventing traditional aluminum-based adjuvants: insight into a century of advancements10.1080/08830185.2024.2404095 ↗
47. Cytokine Regulation and function in T cells10.1146/annurev-immunol-061020-053702 ↗
48. Role of direct effects of IFN-gamma on T cells in the regulation of CD8 T cell homeostasis10.4049/jimmunol.179.4.2115 ↗
49. Revisiting IL-2: biology and therapeutic prospects10.1126/sciimmunol.aat1482 ↗
50. Editorial: B cell activation and differentiation: new perspectives on an enduring topic10.3389/fimmu.2021.797548 ↗
51. Finelli C. Liver-spleen axis: intersection between immunity, infections and metabolism10.3748/wjg.v19.i23.3534 ↗
52. Regulation of adaptive immunity and cytokine production through PLGA nanoparticles modified by cytokine-releasing peptides
53. Hepatic dendritic cells in the development and progression of metabolic steatohepatitis10.3389/fimmu.2021.641240 ↗
54. Engineered macrophage membrane-coated dihydroartemisinin nanoparticles with enhanced CCR2 expression improved symptoms in MRL/LPR mice by metabolic reprogramming of proinflammatory macrophages10.1186/s12967-025-06574-4 ↗